It is imperative that an in vitro model of Alzheimer's Disease be developed; this would greatly improve studies of the mechanism(s) of Alzheimer's disease and allow screening of potential therapeutic agents. In addition, if the model were genetically manipulable, then the gene or genes important for the development of the Alzheimer's pathology could be determined. No such model has been available previously, but data presented in this proposal suggest that an in vitro model of Alzheimer's disease has now been developed (see Preliminary Results). This consists of long-term reaggregating brain cultures of trisomy 16 mouse central nervous system. It is proposed that these studies be extended by (1) characterizing the reaggregating brain cultures of Ts16 mice and control littermates for beta- amyloid production, abnormally phosphorylated tau (i.e., the mouse equivalent of the Alz-50 target), phosphorylated neurofilament, neuronal density vs. time, paired helical filaments, and APP751/APP695 mRNA ratios; and (2) producing temperature-sensitive immortalized T16 neural and glial cells, then transfecting the cell with a reporter expression construct and including the cells in the reaggregating cultures. The long-term goal of this project is to develop and characterize an in vitro model of Alzheimer's disease that will be genetically manipulable. This should allow an evaluation of the region of mouse chromosome 16 that is important for the development of the changes associated with Alzheimer's disease, and, ultimately, determination of the important gene or genes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG010671-03
Application #
3122601
Study Section
Special Emphasis Panel (SRC (33))
Project Start
1991-09-29
Project End
1994-06-30
Budget Start
1993-08-01
Budget End
1994-06-30
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Nguyen, Thuy-Vi V; Galvan, Veronica; Huang, Wei et al. (2008) Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 104:1065-80
Rabizadeh, S; Gralla, E B; Borchelt, D R et al. (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A 92:3024-8
Rabizadeh, S; Bitler, C M; Butcher, L L et al. (1994) Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A 91:10703-6
Zhong, L T; Kane, D J; Bredesen, D E (1993) BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res Mol Brain Res 19:353-5
Rabizadeh, S; Oh, J; Zhong, L T et al. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261:345-8
Rabizadeh, S; LaCount, D J; Friesen, P D et al. (1993) Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J Neurochem 61:2318-21